Foresite Capital Management III as of June 30, 2017
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 26 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 33.5 | $103M | 2.0M | 52.55 | |
| Achaogen | 8.9 | $27M | 1.3M | 21.73 | |
| Alder Biopharmaceuticals | 8.1 | $25M | 2.2M | 11.45 | |
| Blueprint Medicines (BPMC) | 7.6 | $23M | 460k | 50.67 | |
| Aimmune Therapeutics | 6.1 | $19M | 912k | 20.56 | |
| Wave Life Sciences (WVE) | 6.1 | $19M | 1.0M | 18.60 | |
| Immunomedics | 5.6 | $17M | 1.9M | 8.83 | |
| Epizyme | 3.9 | $12M | 799k | 15.10 | |
| Tocagen | 3.0 | $9.1M | 753k | 12.03 | |
| Loxo Oncology | 3.0 | $9.0M | 113k | 80.19 | |
| Fibrogen (FGEN) | 2.6 | $8.1M | 250k | 32.30 | |
| Verona Pharma Plc ads (VRNA) | 2.3 | $7.2M | 614k | 11.66 | |
| Bellicum Pharma | 1.7 | $5.3M | 453k | 11.68 | |
| Dermira | 1.7 | $5.1M | 176k | 29.14 | |
| Pacific Biosciences of California (PACB) | 1.4 | $4.5M | 1.3M | 3.56 | |
| Argenx Se (ARGX) | 1.2 | $3.7M | 177k | 21.21 | |
| Nanostring Technologies (NSTGQ) | 1.0 | $3.0M | 179k | 16.54 | |
| Sangamo Biosciences (SGMO) | 0.4 | $1.4M | 154k | 8.80 | |
| Infinity Pharmaceuticals (INFIQ) | 0.4 | $1.2M | 739k | 1.57 | |
| Orexigen Therapeutics | 0.4 | $1.1M | 381k | 2.90 | |
| Zafgen | 0.3 | $822k | 234k | 3.51 | |
| Biohaven Pharmaceutical Holding | 0.2 | $750k | 30k | 25.00 | |
| Acceleron Pharma | 0.2 | $604k | 20k | 30.37 | |
| Ascendis Pharma A S (ASND) | 0.2 | $622k | 22k | 27.77 | |
| Ardelyx (ARDX) | 0.1 | $191k | 38k | 5.09 | |
| Abeona Therapeutics | 0.0 | $117k | 18k | 6.38 |
